News

Sequel built its twiist system on underlying drug delivery technology developed by DEKA R&D. Dean Kamen, co-founder of Sequel ...
Insulet (Nasdaq:PODD) announced that it named Lisa Blair Davis as its new SVP and chief human resources officer.
Breakthrough T1D (formerly JDRF) and Mattel announced a partnership to debut the first Barbie doll with type 1 diabetes (T1D) ...
The medtech giant announced in May that it planned to separate the Diabetes unit into a standalone, publicly traded company.
Diabeloop today announced the commercial availability of its DBLG1 algorithm with the Dana-i insulin pump from Sooil in ...
Lifecare said on social media that it completed a significant milestone in the development of its continuous glucose monitor ...
Ypsomed announced today that Chinese regulatory authorities approved the a dual GCP/GLP-1 drug delivered using its ...
The biggest names in diabetes tech gathered in Chicago this past weekend for the American Diabetes Association's 85th Scientific Sessions.
While many systems already pair continuous glucose monitors (CGMs) and insulin pumps, PharmaSens and SiBionics may have something different.
BTIG analysts said today that Beta Bionics expects to launch a new insulin patch pump system in the U.S. by the end of 2027.
When it comes to the diabetes tech market, the Insulet Omnipod 5 automated insulin delivery system is nothing new.